Wall Street brokerages expect that H. B. Fuller Company (NYSE:FUL) will report $609.69 million in sales for the current quarter, Zacks reports. Four analysts have provided estimates for H. B. Fuller’s earnings, with estimates ranging from $581.75 million to $662.40 million. H. B. Fuller posted sales of $574.91 million in the same quarter last year, which suggests a positive year-over-year growth rate of 6%. The firm is expected to issue its next quarterly earnings report on Wednesday, January 17th.
According to Zacks, analysts expect that H. B. Fuller will report full year sales of $609.69 million for the current fiscal year, with estimates ranging from $2.21 billion to $2.29 billion. For the next fiscal year, analysts forecast that the business will report sales of $2.34 billion per share, with estimates ranging from $2.32 billion to $2.37 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that follow H. B. Fuller.
H. B. Fuller (NYSE:FUL) last posted its earnings results on Wednesday, September 27th. The specialty chemicals company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.67 by ($0.02). H. B. Fuller had a return on equity of 13.08% and a net margin of 4.76%. The firm had revenue of $562.87 million during the quarter, compared to the consensus estimate of $553.66 million.
FUL has been the subject of several recent analyst reports. BidaskClub cut shares of H. B. Fuller from a “hold” rating to a “sell” rating in a research report on Saturday, August 12th. Zacks Investment Research upgraded shares of H. B. Fuller from a “sell” rating to a “hold” rating in a research report on Thursday, August 17th. KeyCorp restated a “hold” rating on shares of H. B. Fuller in a research report on Thursday, August 24th. Deutsche Bank upped their target price on shares of H. B. Fuller from $56.00 to $58.00 and gave the stock a “hold” rating in a research report on Wednesday, September 6th. Finally, Robert W. Baird initiated coverage on shares of H. B. Fuller in a research report on Thursday, September 14th. They issued a “neutral” rating and a $60.00 target price for the company. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $60.00.
In other news, VP Timothy J. Keenan sold 6,500 shares of the stock in a transaction that occurred on Wednesday, November 8th. The shares were sold at an average price of $55.08, for a total value of $358,020.00. Following the completion of the transaction, the vice president now directly owns 29,611 shares in the company, valued at $1,630,973.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Robert J. Martsching sold 3,870 shares of the stock in a transaction that occurred on Monday, October 23rd. The shares were sold at an average price of $57.93, for a total transaction of $224,189.10. The disclosure for this sale can be found here. Insiders sold 15,767 shares of company stock valued at $897,394 over the last quarter. Insiders own 3.10% of the company’s stock.
Several institutional investors have recently bought and sold shares of the company. Janus Henderson Group PLC acquired a new stake in H. B. Fuller during the second quarter valued at approximately $105,912,000. Principal Financial Group Inc. lifted its stake in H. B. Fuller by 141.0% during the second quarter. Principal Financial Group Inc. now owns 977,899 shares of the specialty chemicals company’s stock valued at $49,980,000 after purchasing an additional 572,177 shares during the last quarter. Westfield Capital Management Co. LP lifted its stake in H. B. Fuller by 135.7% during the third quarter. Westfield Capital Management Co. LP now owns 476,700 shares of the specialty chemicals company’s stock valued at $27,677,000 after purchasing an additional 274,433 shares during the last quarter. Pioneer Investment Management Inc. acquired a new stake in H. B. Fuller during the second quarter valued at approximately $11,091,000. Finally, Amundi Pioneer Asset Management Inc. lifted its stake in H. B. Fuller by 92.4% during the third quarter. Amundi Pioneer Asset Management Inc. now owns 417,610 shares of the specialty chemicals company’s stock valued at $24,247,000 after purchasing an additional 200,594 shares during the last quarter. Institutional investors and hedge funds own 92.35% of the company’s stock.
H. B. Fuller (NYSE FUL) opened at $56.18 on Tuesday. H. B. Fuller has a 1 year low of $46.58 and a 1 year high of $58.74. The company has a quick ratio of 1.72, a current ratio of 2.63 and a debt-to-equity ratio of 0.74. The company has a market cap of $2,801.02, a PE ratio of 22.35 and a beta of 1.72.
ILLEGAL ACTIVITY WARNING: This article was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another publication, it was illegally copied and republished in violation of international copyright and trademark law. The original version of this article can be accessed at https://www.dispatchtribunal.com/2017/12/05/brokerages-anticipate-h-b-fuller-company-ful-will-announce-quarterly-sales-of-609-69-million.html.
About H. B. Fuller
H.B. Fuller Company is a formulator, manufacturer and marketer of adhesives, sealants and other specialty chemical products. The Company’s segments include Americas Adhesives, Europe, India, Middle East and Africa (EIMEA), Asia Pacific, Construction Products and Engineering Adhesives. The Americas Adhesives, EIMEA and Asia Pacific operating segments produce and supply industrial adhesives products for applications in various markets, including durable assembly, nonwoven and hygiene, and textile.
Get a free copy of the Zacks research report on H. B. Fuller (FUL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for H. B. Fuller Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller Company and related companies with MarketBeat.com's FREE daily email newsletter.